PreAxia Health Care Payment Systems Inc. (PAXH)
OTCMKTS · Delayed Price · Currency is USD
0.0479
-0.0471 (-49.58%)
At close: Jun 26, 2025
PAXH Market Cap
PAXH has a market cap or net worth of $946.87 thousand as of July 22, 2025.
Market Cap
946.87K
Enterprise Value
2.66M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.05
Market Cap Chart
Since December 31, 2008, PAXH's market cap has decreased from 2.36M to 946.87K, a decrease of -59.92%. That is a compound annual growth rate of -5.39%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jun 26, 2025 | 946.87K | -49.58% |
May 30, 2025 | 1.88M | 66.68% |
Jul 9, 2024 | 1.13M | - |
Jun 16, 2023 | 1.13M | 0.88% |
Feb 24, 2023 | 1.12M | -87.32% |
Feb 23, 2023 | 8.81M | 688.50% |
Sep 30, 2022 | 1.12M | - |
Sep 23, 2022 | 1.12M | - |
Sep 20, 2022 | 1.12M | -52.92% |
Sep 16, 2022 | 2.37M | -52.00% |
Sep 2, 2022 | 4.94M | 147.52% |
Feb 18, 2022 | 2.00M | 10.38% |
Feb 9, 2022 | 1.81M | -3.68% |
Jul 26, 2021 | 1.88M | - |
Jul 23, 2021 | 1.88M | - |
Jul 19, 2021 | 1.88M | -81.00% |
Jul 13, 2021 | 9.88M | - |
Jul 12, 2021 | 9.88M | - |
Jul 6, 2021 | 9.88M | 300.00% |
Apr 30, 2021 | 2.47M | -16.67% |
Apr 28, 2021 | 2.97M | - |
Apr 26, 2021 | 2.97M | -40.00% |
Apr 23, 2021 | 4.94M | -50.00% |
Apr 22, 2021 | 9.88M | -33.33% |
Apr 14, 2021 | 14.83M | - |
Mar 1, 2021 | 14.83M | - |
Feb 23, 2021 | 14.83M | -25.00% |
Jan 25, 2021 | 19.77M | - |
Jan 11, 2021 | 19.77M | -60.00% |
Jan 4, 2021 | 49.42M | 66.67% |
Sep 18, 2020 | 29.65M | - |
Sep 15, 2020 | 29.65M | 50.00% |
Feb 20, 2020 | Pro | Pro |
Aug 7, 2017 | Pro | Pro |
Jun 19, 2017 | Pro | Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Endo, Inc. | 1.66B |
Veradigm | 781.22M |
Nika Pharmaceuticals | 708.22M |
Tian'an Technology Group | 628.15M |
Elite Pharmaceuticals | 568.58M |
Glass House Brands | 434.98M |
CytoDyn | 394.89M |
Northwest Biotherapeutics | 364.65M |